Genizon Offering High Throughput SNP Genotyping Services

Genizon BioSciences has announced it is providing Single Nucleotide Polymorphism genotyping services for research organizations and the biopharmaceutical industry.

In addition, Genizon offers statistical analysis services using its automated genetic computational pipeline. All services are performed at Genizon’s Montreal-based GLP-compliant facilities.

Genotyping is carried out using eight Illumina BeadArray instruments and custom or off the shelf Illumina Infinium™ chips or GoldenGate™ marker sets, for whole genome studies, candidate gene investigation and other applications.

The platform is designed to operate on a 24/7 basis with a throughput of up to 100 million genotypes per day.

Genetic analysis is performed using GeneSys, the company’s validated software platform running in a high-throughput cluster computing environment.

Basic analysis includes phase determination, single and multi-marker haplotype analysis, as well as genome-wide or study-wide statistical significance analysis.

Customers are also offered the option to run more advanced custom developed algorithms.

"Providing SNP genotyping and genetic analysis services is a natural extension for our company," said Dr. John Hooper, President and CEO of Genizon.

"The high quality of our genotyping in combination with our genetic analysis tools has enabled Genizon to become the industry leader in statistical power for gene discovery."

"We are pleased to extend to others the near 100% call rates, genotyping accuracy and data reproducibility we have achieved in our own studies."

"We have developed unrivaled expertise in SNP genotyping and genetic analysis, conducting seven whole genome association studies which have resulted in over 50 gene discoveries in common diseases."

Genizon’s genotyping service unit is run by Dr. Rene Paulussen, Vice President, Operations, who has extensive experience in high-throughput laboratory operations in the contract research business.